Research suggests dupilumab may help alleviate intense itching and skin pain in prurigo nodularis. A small study found improvements in symptoms over 104 weeks, but more research is needed to confirm these findings. Learn more about this study's results on prurigo nodularis man...
SkinCareRadar tracks newly published skincare and dermatology research, then explains what the findings mean in plain language — with evidence labels, source links, and no hype.
Research suggests dupilumab may help alleviate intense itching and skin pain in prurigo nodularis. A small study found improvements in symptoms over 104 weeks, but more research is needed to confirm these findings. Learn more about this study's results on prurigo nodularis man...
Animal StudyResults in animals only. May or may not translate to humans.Redness / Facial RednessPublished: April 15, 2026
Zerumbone from Ginger Plant May Help Soothe Atopic Dermatitis
Researchers studied zerumbone, a compound from the Zingiber zerumbet plant, to see if it could help with atopic dermatitis. They found that it may reduce inflammation and improve skin barrier function in lab experiments and animal studies. However, more research is needed to confirm these findings.
Why it matters: Understanding natural compounds that may help with atopic dermatitis could lead to new, more accessible treatment options.
This study was conducted in lab experiments and animal models, and more research is needed to confirm its findings in humans. The study's results may not translate directly to human skin conditions.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: April 15, 2026
Dupilumab May Help Manage Prurigo Nodularis Symptoms
A small study of 543 adults with prurigo nodularis found that dupilumab, a treatment for this chronic skin condition, may help reduce symptoms like intense itching and skin pain. Researchers observed improvements in symptoms over a period of 104 weeks. However, more research is needed to confirm these findings.
Why it matters: This study may provide insights into managing prurigo nodularis, a condition that can significantly impair quality of life.
This study was conducted in a real-world setting, but the sample size was relatively large and diverse, and the treatment duration was 104 weeks.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Skin Barrier DamagePublished: April 15, 2026
Nanotechnology may help improve psoriasis treatment
Researchers studied how nanotechnology can be used to deliver drugs to people with psoriasis. They found that combining different treatments within a single nanocarrier platform may be effective. However, more research is needed to confirm these findings.
Why it matters: This study may help us understand how to improve psoriasis treatment and potentially reduce side effects.
This review is based on existing literature and does not present new experimental data. The effectiveness of nanotechnology in treating psoriasis has not been directly tested in this study.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.Skin Barrier DamagePublished: April 15, 2026
Atopic Dermatitis and Psoriasis: Similarities and Differences
Researchers compared atopic dermatitis and psoriasis, two common skin conditions, to understand their similarities and differences. They looked at genetics, natural history, triggers, and skin barrier defects. The study found that, although these conditions share some immunological mechanisms, their clinical implications are distinct.
Why it matters: Understanding the differences between atopic dermatitis and psoriasis may help improve skincare treatments and management of these conditions.
This review is based on existing research and does not present new findings. The authors' conclusions are based on a comprehensive analysis of previous studies.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Systematic ReviewSummary and analysis of existing published studies.AcnePublished: April 14, 2026
Phototherapy May Help Manage Acne Symptoms
Researchers studied phototherapy for acne vulgaris, a chronic inflammatory skin disease. They found that different light-based treatments can target acne through three main pathways: reducing sebum production, controlling inflammation, and improving scar appearance. The effectiveness of these treatments varies depending on the individual's acne type and severity.
Why it matters: Understanding phototherapy's potential benefits and limitations may help individuals with acne make informed decisions about their treatment options.
This review is based on studies published between 2005 and 2025, and the findings may not be applicable to all individuals with acne. The effectiveness of phototherapy can vary depending on the specific treatment and individual characteristics.
◆ Notable findingA finding from a controlled trial, systematic review, or meta-analysis with noteworthy results.Controlled TrialControlled human study, often randomized. Stronger evidence.Published: April 14, 2026
Laser Biostimulation May Help with Immediate Implant Healing
Researchers studied the effects of low-level diode laser biostimulation on immediate implant healing in the maxillary premolars. They found that laser biostimulation may improve implant stability and wound healing in the short term, but its long-term benefits are limited. The study suggests that laser biostimulation may not offer significant additional benefits over conventional methods.
Why it matters: This study may help us understand how laser biostimulation affects tissue healing, which could have implications for various medical treatments, including skincare.
This study had a small sample size of 20 patients and was conducted over a short period of 4 months.
SkinCareRadar is a public research monitor focused on skincare ingredients, routines, devices, and skin conditions and concerns. It translates dermatology and cosmetic science research into plain language for the general public.
Every finding is linked to its original source. Evidence stages are labeled clearly. We do not diagnose, recommend treatment, or give medical advice. We distinguish cosmetic improvement from medically significant outcomes.